Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors
Clinical trial NCT06302062 · RECRUITING
Trial details
- NCT number
- NCT06302062
- Sponsor
- Guangzhou FineImmune Biotechnology Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2025-12-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.